Clinical Trial Update: Erector Spinae Plane Block in Congenital Heart Disease Patients [NA]

View source ↗

Summary

Clinical trial at Stanford is evaluating the use of erector spinae plane block in children with congenital heart disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Neurological Disorders

Snippet

Sponsor: Stanford University | Conditions: Congenital Heart Disease in Children, Neurologic Complication | NA | Status: NOT_YET_RECRUITING